BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37118071)

  • 21. Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism.
    Smailovic U; Koenig T; Savitcheva I; Chiotis K; Nordberg A; Blennow K; Winblad B; Jelic V
    Brain Connect; 2020 Dec; 10(10):555-565. PubMed ID: 33073602
    [No Abstract]   [Full Text] [Related]  

  • 22. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI or
    Doering E; Antonopoulos G; Hoenig M; van Eimeren T; Daamen M; Boecker H; Jessen F; Düzel E; Eickhoff S; Patil K; Drzezga A;
    J Nucl Med; 2024 Jan; 65(1):147-155. PubMed ID: 38050112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes.
    Jack CR; Wiste HJ; Botha H; Weigand SD; Therneau TM; Knopman DS; Graff-Radford J; Jones DT; Ferman TJ; Boeve BF; Kantarci K; Lowe VJ; Vemuri P; Mielke MM; Fields JA; Machulda MM; Schwarz CG; Senjem ML; Gunter JL; Petersen RC
    Brain; 2019 Oct; 142(10):3230-3242. PubMed ID: 31501889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.
    Chouliaras L; Thomas A; Malpetti M; Donaghy P; Kane J; Mak E; Savulich G; Prats-Sedano MA; Heslegrave AJ; Zetterberg H; Su L; Rowe JB; O'Brien JT
    J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):651-658. PubMed ID: 35078917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
    Wirth M; Villeneuve S; Haase CM; Madison CM; Oh H; Landau SM; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2013 Dec; 70(12):1512-9. PubMed ID: 24166579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated functional brain aging in pre-clinical familial Alzheimer's disease.
    Gonneaud J; Baria AT; Pichet Binette A; Gordon BA; Chhatwal JP; Cruchaga C; Jucker M; Levin J; Salloway S; Farlow M; Gauthier S; Benzinger TLS; Morris JC; Bateman RJ; Breitner JCS; Poirier J; Vachon-Presseau E; Villeneuve S; ; ;
    Nat Commun; 2021 Sep; 12(1):5346. PubMed ID: 34504080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach.
    Dai Y; Hsu YC; Fernandes BS; Zhang K; Li X; Enduru N; Liu A; Manuel AM; Jiang X; Zhao Z;
    J Alzheimers Dis; 2024; 97(4):1807-1827. PubMed ID: 38306043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 3D convolutional neural network to classify subjects as Alzheimer's disease, frontotemporal dementia or healthy controls using brain 18F-FDG PET.
    Rogeau A; Hives F; Bordier C; Lahousse H; Roca V; Lebouvier T; Pasquier F; Huglo D; Semah F; Lopes R
    Neuroimage; 2024 Mar; 288():120530. PubMed ID: 38311126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
    Ossenkoppele R; Rabinovici GD; Smith R; Cho H; Schöll M; Strandberg O; Palmqvist S; Mattsson N; Janelidze S; Santillo A; Ohlsson T; Jögi J; Tsai R; La Joie R; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; Choi JY; Ryu YH; Lyoo CH; Hansson O
    JAMA; 2018 Sep; 320(11):1151-1162. PubMed ID: 30326496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.
    Lee DH; Lee P; Seo SW; Roh JH; Oh M; Oh JS; Oh SJ; Kim JS; Jeong Y
    Neuroimage; 2019 Feb; 186():690-702. PubMed ID: 30503934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep learning detection of informative features in tau PET for Alzheimer's disease classification.
    Jo T; Nho K; Risacher SL; Saykin AJ;
    BMC Bioinformatics; 2020 Dec; 21(Suppl 21):496. PubMed ID: 33371874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfer learning for predicting conversion from mild cognitive impairment to dementia of Alzheimer's type based on a three-dimensional convolutional neural network.
    Bae J; Stocks J; Heywood A; Jung Y; Jenkins L; Hill V; Katsaggelos A; Popuri K; Rosen H; Beg MF; Wang L;
    Neurobiol Aging; 2021 Mar; 99():53-64. PubMed ID: 33422894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiating Alzheimer's Disease from Dementia with Lewy Bodies Using a Deep Learning Technique Based on Structural Brain Connectivity.
    Wada A; Tsuruta K; Irie R; Kamagata K; Maekawa T; Fujita S; Koshino S; Kumamaru K; Suzuki M; Nakanishi A; Hori M; Aoki S
    Magn Reson Med Sci; 2019 Jul; 18(3):219-224. PubMed ID: 30504639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring Links Between Psychosis and Frontotemporal Dementia Using Multimodal Machine Learning: Dementia Praecox Revisited.
    Koutsouleris N; Pantelis C; Velakoulis D; McGuire P; Dwyer DB; Urquijo-Castro MF; Paul R; Dong S; Popovic D; Oeztuerk O; Kambeitz J; Salokangas RKR; Hietala J; Bertolino A; Brambilla P; Upthegrove R; Wood SJ; Lencer R; Borgwardt S; Maj C; Nöthen M; Degenhardt F; Polyakova M; Mueller K; Villringer A; Danek A; Fassbender K; Fliessbach K; Jahn H; Kornhuber J; Landwehrmeyer B; Anderl-Straub S; Prudlo J; Synofzik M; Wiltfang J; Riedl L; Diehl-Schmid J; Otto M; Meisenzahl E; Falkai P; Schroeter ML;
    JAMA Psychiatry; 2022 Sep; 79(9):907-919. PubMed ID: 35921104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
    Kishore N; Goel N
    Neurosci Lett; 2023 Nov; 817():137530. PubMed ID: 37858874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting mild cognitive impairments from cognitively normal brains using a novel brain age estimation model based on structural magnetic resonance imaging.
    Choi US; Park JY; Lee JJ; Choi KY; Won S; Lee KH
    Cereb Cortex; 2023 Oct; 33(21):10858-10866. PubMed ID: 37718166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.